Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹600.00 Cr |
| Fresh Issue | ₹300.00 Cr |
| Offer for Sale | ₹300.00 Cr |
| Face Value | ₹2 Per Equity Share |
| Price Band | ₹129.00-130.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543277 |
| NSE Code | LXCHEM |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Dam Capital Advisors Ltd. |
| Allotment Status | |
| DRHP |
| RHP |
| Final Prospectus |
| Anchor List |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 115 shares and in multiples thereof
Incorporated in 1989, Laxmi Organic Industries Ltd is a specialty chemical manufacturer that operates in 2 business segments; Acetyl Intermediates (AI) and Specialty Intermediates (SI). It is the leading manufacturer of ethyl acetate with over 30% market share in the Indian ethyl acetate market and the only manufacturer of diketene derivatives in India.
Its AI segment includes ethyl acetate, acetaldehyde, fuel-grade ethanol, and other proprietary solvents whereas the SI segment includes ketene, diketene derivatives namely esters, acetic anhydride, arylides, amides, and other chemicals. Its products are being used in various industries like pharmaceuticals, agrochemicals, inks & coatings, dyes & pigments, paints, printing & packaging, etc. Alembic Pharmaceuticals Limited, Laurus Labs Limited, Granules India Limited, Hetero Labs Limited, Heubach Colour Private Limited, Hubergroup India Private Limited, Huhtamaki India Limited, Macleods Pharmaceuticals Private Limited, Suven Pharmaceuticals Limited, Colourtex Industries Private Limited, and UPL Limited are some of its customers.
The company has a global footprint with customers in 30 countries including but not restricted to China, Russia, Singapore, UAE, UK, USA, Netherland, etc. Currently, it has 2 manufacturing facilities in Mahad, Maharashtra for the manufacturing of AI and SI products. It is also proposing to set-up a new manufacturing facility at Lote Parshuram, Maharashtra to manufacture four specialty chemicals.
Competitive Strengths
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in YFCPL for part-financing itscapital expenditure requirements in relation to the setting up of the Proposed Facility | 60.40 |
| 2 | Investment in YFCPL for funding its working capital requirements of YFCPL | 37.74 |
| 3 | Funding capital expenditure requirements for expansion of our SI Manufacturing Facility | 91.06 |
| 4 | Funding working capital requirements of our Company | 35.18 |
| 5 | Purchase of plant and machinery for augmenting infrastructure development at our SI Manufacturing Facility | 12.57 |
| 6 | Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company and VLPL | 179.31 |
| 7 | General corporate purposes | 63.73 |
| Period Ended | 30 Sep 2020 | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2018 |
|---|---|---|---|---|
| Assets | 1,037.13 | 1,070.63 | 1,014.49 | 894.73 |
| Total Income | 814.36 | 1,538.62 | 1,574.32 | 1,396.08 |
| Profit After Tax | 45.48 | 70.21 | 72.39 | 75.70 |
| EBITDA | 86.34 | 143.71 | 158.62 | 154.41 |
| NET Worth | 471.45 | 425.96 | 448.89 | 378.37 |
| Reserves and Surplus | 427.39 | 381.90 | 399.80 | 369.31 |
| Total Borrowing | 192.18 | 158.84 | 175.33 | 215.06 |
| Amount in ₹ Crore | ||||
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLMs’ fees and commissions (including underwriting commission, brokerage and selling commission) | 14.16 |
| 2 | Selling commission payable to SCSBs for Bids directlyprocured by them and processing fees payable to SCSBs for Bids (other than Bids submitted by RIIs using the UPI Mechanism) procured by the members of the Syndicate, the Registered Brokers, CRTAs or CDPs and submitted to SCSBs for blocking, Bankers to the Offer, fees payable to the Sponsor Bank for Bids made by RIIs | 1.08 |
| 3 | Selling commission and uploading charges payable to members of the Syndicate (including their sub-Syndicate Members), CRTAs, CDPs and Registered Brokers | 3.75 |
| 4 | Processing fees payable to the Sponsor Bank | 0.80 |
| 5 | Fees payable to the Registrar to the Offer | 0.30 |
| 6 | Listing fees, SEBI filing fees, upload fees, Stock Exchanges processing fees, book building software fees and other regulatory expenses | 4.26 |
| 7 | Printing and stationery expenses | 2.54 |
| 8 | Advertising and marketing expenses | 2.18 |
| 9 | Fees payable to legal counsels | 1.57 |
| 10 | Fees payable to the Monitoring Agency | 0.01 |
| 11 | Miscellaneous | 1.42 |
Last Updated on 17-Jul-2026 15:25:12
